Expert Interview
Discussing the potential impact of T regulatory (Treg) directed therapies in diabetes.
Ticker(s): NKTRInstitution: University of Miami
- Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, & Metabolism University of Miami, Miller School of Medicine
- Focus on the management of islet transplant recipients, development of new clinical trials for islet transplantation, and testing of novel therapies for the treatment of patients with new onset type 1 diabetes.
- Currently serves as PI/co-PI in multiple T1D trials including pancreatic beta cell replacement strategies
How are you currently treating T1D patients?
Added By: wilson_adminCan you elaborate on on the role that tregs play in the pathogenesis of T1D
Added By: wilson_adminHow optimistic are you on Rezpegaldesleukin as a therapeutic option for T1D
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
